Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global $5 Billion Influenza Vaccines Market and Forecast to 2021 - Size, Share, Growth and Trends Analysis - Research and Markets

Research and Markets
Posted on: 29 Nov 16

Research and Markets has announced the addition of the "Global Influenza Vaccines Market and Forecast to 2021 - Size, Share, Growth and Trends Analysis" report to their offering.

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2021

Global Influenza Vaccines Market and Forecast to 2021 - Size, Share, Growth and Trends Analysis provides a comprehensive analysis of the fast-evolving influenza vaccines market.

Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

Geographically, North America is the largest market for influenza vaccines capturing around 50% market share in 2015. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America. Australasia accounted for least share of the influenza vaccines market in 2015.

On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines in 2015.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

The Influenza Vaccines Market have been analyzed from 5 viewpoints:

- Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2021)

- Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)

- Global - Influenza Vaccines Brand Sales and Forecast to 2021

- Global Influenza Vaccines Market - Major Deals

- Global Influenza Vaccines Market - Driving Factors and Challenges

Key Topics Covered:

1. Executive Summary

2. Global - Influenza Vaccines Market Analysis and Forecast (2011 - 2020)

3. Global - Influenza Vaccines Market Share Analysis and Forecast

4. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2021)

5. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)

6. Global - Influenza Vaccines Brand Sales and Forecast

7. Influenza Vaccines Market - Major Deals

8. Global Influenza Vaccines Market - Driving Factors

9. Global Influenza Vaccines Market - Challenges

Companies Mentioned

  • AstraZeneca
  • CSL Ltd
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Protein Sciences
  • Sanofi Pasteur

For more information about this report visit http://www.researchandmarkets.com/research/8cmmtb/global_influenza

View source version on businesswire.com: http://www.businesswire.com/news/home/20161129005887/en/

Business Wire
www.businesswire.com

Last updated on: 29/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.